case_images: PMC11075175_01
case_images: Platelet count over the course of treatment.
case_images: CNCS-12-036-01.jpg
case_images: PMC11075175_01_CNCS-12-036-01.jpg
case_images: Figure1
case_images: Platelet count began to improve after receiving a 2nd dose of rituximab and increased to above 150,000/microL (Figure 1) following the completion of the 4th dose of rituximab. TPE was restarted due to unresponsiveness (Figure 1). There was a notable response after the 1st dose of rituximab re-initiation, particularly in the platelet count before the decision was made to start caplacizumab.